These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28464542)

  • 1. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.
    Shiao JC; Mohamed ASR; Messer JA; Hutcheson KA; Johnson JM; Enderling H; Kamal M; Warren BW; Pham B; Morrison WH; Zafereo ME; Hessel AC; Lai SY; Kies MS; Ferrarotto R; Garden AS; Schomer DF; Gunn GB; Phan J; Frank SJ; Beadle BM; Weber RS; Lewin JS; Rosenthal DI; Fuller CD
    Head Neck; 2017 Aug; 39(8):1609-1620. PubMed ID: 28464542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.
    Hsin LJ; Fang TJ; Tsang NM; Chin SC; Yen TC; Li HY; Liao CT; Chen IH
    Laryngoscope; 2014 May; 124(5):1134-40. PubMed ID: 24127228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy.
    Gorphe P; Matias M; Moya-Plana A; Tabarino F; Blanchard P; Tao Y; Janot F; Temam S
    Ann Surg Oncol; 2016 Aug; 23(8):2596-601. PubMed ID: 27034080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
    Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
    Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
    Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.
    Timmermans AJ; Lange CA; de Bois JA; van Werkhoven E; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Laryngoscope; 2016 Feb; 126(2):E60-7. PubMed ID: 26333005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neck Management with Total Laryngectomy and Adjuvant Radiotherapy in Locally Advanced Larynx Cancer.
    Kennedy WR; Amdur RJ; Boyce BJ; Dziegielewski P; Morris CG; Mendenhall WM
    Oncol Res Treat; 2017; 40(9):503-506. PubMed ID: 28848123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
    Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary organ preservation vs total laryngectomy for T4a larynx cancer.
    Oh J; Prisman E; Olson R; Berthelet E; Wu J; Tran E; Bakos B; Kaviani R; Hamilton SN
    Head Neck; 2019 Sep; 41(9):3265-3275. PubMed ID: 31215719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    Dyckhoff G; Plinkert PK; Ramroth H
    BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.